Parallel genome-wide RNAi screens identify lymphocyte-specific protein tyrosine kinase (LCK) as a targetable vulnerability of cell proliferation and chemoresistance in nasopharyngeal carcinoma-Reference-Cited by-同舟云学术

Parallel genome-wide RNAi screens identify lymphocyte-specific protein tyrosine kinase (LCK) as a targetable vulnerability of cell proliferation and chemoresistance in nasopharyngeal carcinoma

Published:2021-04 Issue: Volume:504 Page:81-90
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Liew Kitson,Yu Gibson Qi Sheng,Wei Pua Lesley Jia,Wong Li Zhe,Tham Shiau Ying^ORCID,Hii Ling-Wei^ORCID,Lim Wei-Meng,OuYong Brian Ming^ORCID,Looi Chin King,Mai Chun-Wai^ORCID,Fei-Lei Chung Felicia^ORCID,Tan Lu Ping,Ahmad Munirah,Soo-Beng Khoo Alan^ORCID,Leong Chee-Onn^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference69 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;Ca - Cancer J. Clin.,2018

2. Nasopharyngeal carcinoma;Chua;Lancet,2016

3. Nasopharyngeal carcinoma;Chen;Lancet,2019

4. Global trends in incidence and mortality of nasopharyngeal carcinoma;Tang;Canc. Lett.,2016

5. Nutlin-3 sensitizes nasopharyngeal carcinoma cells to cisplatin-induced cytotoxicity;Voon;Oncol. Rep.,2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. METTL14 promotes lipid metabolism reprogramming and sustains nasopharyngeal carcinoma progression via enhancing m⁶A modification of ANKRD22 mRNA;Clinical and Translational Medicine;2024-07

2. Unlocking Clinical Insights: Lymphocyte-Specific Protein Tyrosine Kinase Candidates as Promising Therapeutic Targets for Pancreatic Cancer Risk Stratification;Cancer Biotherapy and Radiopharmaceuticals;2024-06-05

3. Advances in Metal-Based Compounds as Emerging Therapeutics for Cancer Treatment;Interdisciplinary Cancer Research;2024

4. Targeting the crosstalk of epigenetic modifications and immune evasion in nasopharyngeal cancer;Cell Biology and Toxicology;2023-09-27

5. Targeting cancer-inducing inflammation: Current advancements and future prospects;Recent Developments in Anti-Inflammatory Therapy;2023